Sarah Griffiths (Nee Klee)
About Sarah Griffiths (Nee Klee)
Sarah Griffiths is an In Vitro Pharmacologist specializing in assay development and screening at BenevolentAI in Cambridge, United Kingdom. She has over 20 years of experience in the biotechnology industry, with a strong background in molecular biology and cell biology.
Current Role at BenevolentAI
Sarah Griffiths serves as an In-vitro Pharmacologist specializing in Assay Development and Screening at BenevolentAI in Cambridge, United Kingdom. Her work involves developing and optimizing in-vitro assays to support drug discovery initiatives. With a focus on cell biology, she contributes to the identification and validation of potential therapeutic targets.
Experience at Cancer Research UK Therapeutic Discovery Labs
Sarah Griffiths worked at Cancer Research UK Therapeutic Discovery Labs, formerly known as Cancer Research Technology, from 2007 to 2019. Based in Cambridge, United Kingdom, she served as a Scientist for 12 years, playing a crucial role in cancer research and therapeutic discovery. Her contributions during this time significantly supported the organization's mission to develop new cancer treatments.
Earlier Career at Spirogen and Cambridge Antibody Technology
Prior to her role at Cancer Research UK, Sarah Griffiths gained significant early career experience as a Research Assistant. She worked at Spirogen in London from 2004 to 2007, focusing on molecular biology projects. Before that, she was a Research Assistant at Cambridge Antibody Technology from 2001 to 2004, where she contributed to research on antibody technology.
Educational Background
Sarah Griffiths has a strong academic background in the biosciences. She earned a Master's degree in Infectious Diseases from the London School of Hygiene and Tropical Medicine from 2006 to 2009. Additionally, she holds a Bachelor's degree in Molecular Biology from the University of Hertfordshire, completed between 1996 and 2000. Her education has underpinned her extensive career in assay development and in-vitro pharmacology.
Specialization in Assay Development and Screening
Sarah Griffiths specializes in assay development and screening within the field of in-vitro pharmacology. Her expertise involves designing, developing, and optimizing assays to test the efficacy and safety of potential therapeutic compounds. With over 20 years of experience in the biotechnology industry, she has established herself as a skilled professional in this critical area of drug discovery.